Cancer immunology researchers are awarded a Nobel Prize, and a seventh immune checkpoint inhibitor is approved by the U.S. Food and Drug Administration.

by Kate Yandell

A study characterizes “chemo brain” in breast cancer patients treated with chemotherapy, and physicians and scientists gather in Toronto to present their lung cancer research.

by Kate Yandell

Patients weigh in on the impact of end-of-treatment bells in cancer centers, and a study suggests that current protocols for BRCA screening may miss testing some patients with mutations.

by Kate Yandell

An article sparks discussion about precision medicine hype, and a study tallies the rare fatal side effects of immune checkpoint inhibitors.

by Kate Yandell

A study quantifies gains in breast cancer survival in young women, and a cancer doctor reflects on her experience as a cancer patient.

by Kate Yandell

A study discusses the harms of breast cancer surgery for women in nursing homes, and an oncologist reflects on the use of military metaphors in writing about John McCain's cancer.

by Kate Yandell

Researchers investigate how often retailers sell cigarettes to minors, and a trial shows the benefits of immunotherapy for melanoma patients with brain metastases.

by Kate Yandell

Researchers suggest reclassification of low-risk cancers, and an immunotherapy drug is approved for small cell lung cancer.

by Kate Yandell

Organizations work to broaden eligibility for cancer clinical trials, and an article explores the limitations of personalized mouse models.

by Kate Yandell

A study indicates that being diagnosed with cancer as a child could lead to financial problems later, and the Trump administration relaxes restrictions on short-term health insurance policies.

by Kate Yandell